Matrine Sodium Chloride Injection
Function and Efficacy
Pharmacological action: In the liver injury model caused by carbon tetrachloride, this product can reduce the serum transaminase and hydroxyproline content in the liver of animals, alleviate the degree of liver lesions and reduce the serum DHBV-DNA level of ducks infected with hepatitis B virus (HBV).
Ingredients
The main ingredient of this product is matrine, also known as oxymatrine.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| AmmothamnineIngredients |
In the liver injury model caused by carbon tetrachloride, this product can reduce the serum transaminase and hydroxyproline content in the liver of animals, alleviate the degree of liver lesions and reduce the serum DHBV-DNA level of ducks infected with hepatitis B virus (HBV). More |
16837-52-8 | 11 |
Appearance
This product is a colorless or almost colorless clear liquid.
Indication
Used for the treatment of chronic hepatitis B.
Usage and Dosage
Intravenous drip: once a day, 0.4-0.6g each time.
Adverse Reactions
The incidence of adverse reactions is low. Common adverse reactions include dizziness, nausea, vomiting, bitter taste in the mouth, diarrhea, upper abdominal discomfort or pain, and occasionally rash, chest tightness, and fever. Symptoms generally resolve on their own. Some patients may experience redness at the injection site.
Precautions
1. Patients who are allergic to this product are prohibited from using it. 2. Patients with severe blood, heart, liver, kidney and endocrine diseases are prohibited from using it.
Drug Interactions
It has a synergistic effect with central nervous system depressants such as chloral hydrate, an antagonistic effect on central nervous system stimulants such as amphetamine, and can facilitate the convulsive effect of strychnine.
Storage
Keep in a sealed container. The validity period is tentatively set at one and a half years.
Packaging Specification
100ml: 0.6g of matrine (as oxymatrine) and 0.9g of sodium chloride